Effect of antihypertensive therapy on endothelial markers in newly diagnosed Stage 1 hypertension: a randomized single-centre study

Sendur M. A. N., Guven G. S., YORGUN H., Ates A. H., Canpolat U., Sunman H., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.14, sa.4, ss.363-369, 2014 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/akd.2014.4793
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.363-369
  • Anahtar Kelimeler: flow mediated vasodilatation, endothelial biomarkers, antihypertensive treatment, BLOOD-PRESSURE, DYSFUNCTION, NEBIVOLOL, DILATION, RISK, TELMISARTAN, ARTERIES, SYSTEM
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: This study was aimed to investigate the effects of olmesartan or nebivolol treatment on blood pressure and some endothelial function markers in newly diagnosed patients with stage 1 essential hypertension.